ABT-431: the diacetyl prodrug of A-86929, a potent and selective dopamine D1 receptor agonist: in vitro characterization and effects in animal models of Parkinson's disease.

Shiosaki, K; Jenner, P; Asin, K E; Britton, D R; Lin, C W; Michaelides, M; Smith, L; Bianchi, B; Didomenico, S; Hodges, L; Hong, Y; Mahan, L; Mikusa, J; Miller, T; Nikkel, A; Stashko, M; Witte, D; Williams, M

Shiosaki, K; Jenner, P; Asin, K E; Britton, D R; Lin, C W; Michaelides, M; Smith, L; Bianchi, B; Didomenico, S; Hodges, L; Hong, Y; Mahan, L; Mikusa, J; Miller, T; Nikkel, A; Stashko, M; Witte, D; Williams, M.

Affiliation

Shiosaki K; Pharmaceutical Products Division, Abbott Laboratories, Abbott Park, Illinois, USA.

J Pharmacol Exp Ther ; 276(1): 150-60, 1996 Jan.

Article de En | MEDLINE | ID: mdl-8558425

Sujet(s)

Recherche sur Google

Ajouter à My VHL

Imprimer

XML

PubMed Links

Collection: 01-internacional Base de données: MEDLINE Sujet principal: Syndrome parkinsonien secondaire / Pyridines / 1,2,3,4-Tétrahydro-naphtalènes / Thiophènes / Promédicaments / Récepteur dopamine D1 / Quinolinone / Agonistes de la dopamine / Antiparkinsoniens Type d'étude: Prognostic_studies Limites: Animals / Female / Humans / Male Langue: En Journal: J Pharmacol Exp Ther Année: 1996 Type de document: Article Pays d'affiliation: États-Unis d'Amérique

Recherche sur Google

Ajouter à My VHL

Imprimer

XML

PubMed Links